β-Cell Autoimmunity, Genetic Susceptibility, and Progression to Type 1 Diabetes in Unaffected Schoolchildren
Open Access
- 1 January 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (1), 171-173
- https://doi.org/10.2337/diacare.24.1.171-a
Abstract
The reported frequencies of autoantibodies in the general population have varied widely. In the present study, the frequencies of ICA (islet cell antibodies), GADA (GAD antibodies), IA-2A (antibodies to IA-2 protein), and IAA (insulin autoantibodies) were 2.8, 0.5, 0.6, and 0.9%, respectively. Multiple antibodies (i.e., two or more) were detected in 21 children (0.6%), and 9 children (0.25%) had three or four antibody specificities in their initial blood sample. The present cut-off limits for antibody-positivity (determined as the 99th percentile in >370 healthy control subjects) are close to the 99.5th percentile for IA-2A and GADA and the 99.0th percentile for IAA in the present series of 3,652 children. The use of different approaches for the definition of cut-off limits (1,2) resulted in somewhat higher frequencies of autoantibodies, although this did not improve the diagnostic sensitivity of any autoantibody. These data illustrate the difficulties in defining borderline positivity and in directly comparing of results from different studies, and emphasize the need for common international standards to be used in these autoantibody assays.Keywords
This publication has 6 references indexed in Scilit:
- Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildrenDiabetologia, 2000
- Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.Diabetes Care, 1999
- Karlsburg Type I diabetes risk study of a general population: frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildrenDiabetologia, 1999
- Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody MarkersDiabetes, 1997
- Prediction of IDDM in the general population: strategies based on combinations of autoantibody markersDiabetes, 1997
- Definition of cut-off points for autoantibody assays in cohorts of healthy individualsThe Lancet, 1996